Atossa Therapeutics
ATOS
ATOS
19 hedge funds and large institutions have $1.51M invested in Atossa Therapeutics in 2020 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
17% less funds holding
Funds holding: 23 → 19 (-4)
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
Holders
19
Holding in Top 10
–
Calls
$91K
Puts
$48K
Top Buyers
| 1 | +$397K | |
| 2 | +$294K | |
| 3 | +$262K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$53.5K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$18.5K |
Top Sellers
| 1 | -$102K | |
| 2 | -$52K | |
| 3 | -$41K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$29K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$11K |